Back to results
US 6,692,919 B1Granted
Activated forms of notch and methods based thereon
AssigneeYale University
InventorsSpyridon Artavanis-Tsakonas, Huilin Qi, Matthew D. Rand
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeYale University
InventorsSpyridon Artavanis-Tsakonas, Huilin Qi, Matthew D. Rand
Estimating the term…
The present invention is directed to methods for detecting or measuring Notch activation by observing or measuring the appearance of Notch on the cell surface or by observing or measuring Notch cleavage products that are indicative of Notch activation. The present invention is also directed to methods for detecting a molecule that modulates Notch activation by observing or measuring a change in the amount of Notch expressed on the cell surface or a change in the amount or pattern of Notch cleavage products. The present invention is also directed to a substantially purified activated heterodimeric form of Notch and components thereof and pharmaceutical compositions and kits thereof. The present invention is based, at least in part, on the discovery that Notch in its active form, i.e., the form that mediates signal transduction and that binds Notch ligands such as Delta, is a heterodimer of an about 180 kDa subunit (NEC) and an about 110 kDa subunit (NTM), which are tethered together through a reducing agent-sensitive linkage, in particular, a non-covalent, metal ion-dependent linkage.
A method for detecting or measuring the form of Notch that mediates Notch signal transduction in a sample of cells comprising detecting or measuring the expression of a Notch heterodimer containing a reducing agent-sensitive linkage on the surface of cells in said cell sample, in which the heterodimer consists of an amino-terminal fragment of full-length Notch terminating between the epidermal growth factor-like repeat domain and the transmembrane domain of full-length Notch, and a carboxy-terminal fragment of full-length Notch with its amino terminus situated between the epidermal growth factor-like repeat domain and the transmembrane domain, and comparing said detected or measured expression to the detected or measured expression of full length Notch in said cells, wherein the presence and amount of Notch on the surface of said cells compared to the presence and amount, respectively, of full length Notch in said cells indicates the relative presence and amount, respectively, of the form of Notch that mediates Notch signal transduction.
A method for detecting or measuring the form of Notch that mediates Notch signal transduction in a sample of cells comprising detecting or measuring the expression of a Notch heterodimer containing a reducing agent-sensitive linkage in said cells, and comparing said detected or measured expression of Notch heterodimer to the detected or measured expression of full length Notch in said cells, wherein the presence and amount of said Notch heterodimer compared to the presence and amount, respectively, of full length Notch in said cells indicates the relative presence and amount, respectively, of the form of Notch that mediates Notch signal transduction, in which the heterodimer consists of NEC and NTM.
Dependencies are inferred from the claim text.